Method for treating obesity and non alcoholic fatty liver disease or non alcoholic steatohepatitis using glucagon receptor antagonist antibody

摘要

The present disclosure relates to methods for treating or preventing obesity and / or nonalcoholic fatty liver disease (NAFLD) and / or nonalcoholic steatohepatitis (NASH) using a glucagon receptor blocker. In various embodiments, the present disclosure provides for treating or preventing NAFLD / NASH using antagonistic antigen binding proteins, such as fully human antibodies, that specifically bind to and antagonize the function of the human glucagon receptor. Regarding the method. [Selection] Figure 3